ciprofloxacin has been researched along with Cronobacter Infections in 148 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The clinical efficacy and tolerability of ciprofloxacin orally administered at the dosage of 250 mg twice a day was evaluated in 25 patients affected by acute bacterial pharyngotonsillitis." | 9.06 | Oral ciprofloxacin for treatment of acute bacterial pharyngotonsillitis. ( D'Errico, G; Esposito, S; Montanaro, C, 1990) |
| "The clinical and bacteriological efficacy of ciprofloxacin was studied in three groups composed of 20 patients each, all of whom were affected by chronic otitis media in the acute stage." | 9.06 | Topical and oral treatment of chronic otitis media with ciprofloxacin. A preliminary study. ( D'Errico, G; Esposito, S; Montanaro, C, 1990) |
| "In a double-blind, randomized, placebo-controlled trial 50 adult patients with acute diarrhea received either 500 mg ciprofloxacin b." | 9.06 | Ciprofloxacin in the treatment of acute bacterial diarrhea: a double blind study. ( Diridl, G; Pichler, H; Wolf, D, 1986) |
| "Thirty two patients with proven chronic bacterial prostatitis were treated with ciprofloxacin 500 mg twice daily orally for four weeks." | 9.06 | Treatment of chronic bacterial prostatitis with ciprofloxacin. ( de Leur, EJ; Ferwerda, WH; Hoogkamp-Korstanje, JA; Langemeyer, TN; Schipper, JJ; van der Wal, T; van Oort, H, 1987) |
| " As far as we know, this is the first case of near-drowning-associated pneumonia with bacteremia caused by coinfection with methicillin-susceptible Staphylococcus aureus and Edwardsiella tarda in a healthy patient." | 7.83 | Near-drowning-associated pneumonia with bacteremia caused by coinfection with methicillin-susceptible Staphylococcus aureus and Edwardsiella tarda in a healthy white man: a case report. ( Cavallaro, MC; Chehter, N; Del Nero, LG; Marta, GN; Zambon, LS, 2016) |
| "The penetration, pharmacokinetics and therapeutic efficacy of fleroxacin and pefloxacin were investigated in a rat abscess model." | 7.67 | The pharmacokinetics and therapeutic efficacy of fleroxacin and pefloxacin in a rat abscess model. ( Barzilai, A; Keren, G; Leibovitz, E; Rubinstein, E; Shabtai, M, 1989) |
| "Trimethoprim/sulfamethoxazole is currently considered the treatment of choice for shigellosis and severe travelers' diarrhea." | 6.16 | Current problems in antimicrobial therapy for bacterial enteric infection. ( DuPont, HL; Ericsson, CD; Johnson, PC; Robinson, A, 1987) |
| "The clinical efficacy and tolerability of ciprofloxacin orally administered at the dosage of 250 mg twice a day was evaluated in 25 patients affected by acute bacterial pharyngotonsillitis." | 5.06 | Oral ciprofloxacin for treatment of acute bacterial pharyngotonsillitis. ( D'Errico, G; Esposito, S; Montanaro, C, 1990) |
| "The clinical and bacteriological efficacy of ciprofloxacin was studied in three groups composed of 20 patients each, all of whom were affected by chronic otitis media in the acute stage." | 5.06 | Topical and oral treatment of chronic otitis media with ciprofloxacin. A preliminary study. ( D'Errico, G; Esposito, S; Montanaro, C, 1990) |
| "In a double-blind, randomized, placebo-controlled trial 50 adult patients with acute diarrhea received either 500 mg ciprofloxacin b." | 5.06 | Ciprofloxacin in the treatment of acute bacterial diarrhea: a double blind study. ( Diridl, G; Pichler, H; Wolf, D, 1986) |
| "Thirty two patients with proven chronic bacterial prostatitis were treated with ciprofloxacin 500 mg twice daily orally for four weeks." | 5.06 | Treatment of chronic bacterial prostatitis with ciprofloxacin. ( de Leur, EJ; Ferwerda, WH; Hoogkamp-Korstanje, JA; Langemeyer, TN; Schipper, JJ; van der Wal, T; van Oort, H, 1987) |
| " The vast majority of Enterobacteriaceae, including ESBL producers, remain susceptible to carbapenems, and these agents are considered preferred empiric therapy for serious Enterobacteriaceae infections." | 4.83 | Resistance in gram-negative bacteria: enterobacteriaceae. ( Paterson, DL, 2006) |
| " As far as we know, this is the first case of near-drowning-associated pneumonia with bacteremia caused by coinfection with methicillin-susceptible Staphylococcus aureus and Edwardsiella tarda in a healthy patient." | 3.83 | Near-drowning-associated pneumonia with bacteremia caused by coinfection with methicillin-susceptible Staphylococcus aureus and Edwardsiella tarda in a healthy white man: a case report. ( Cavallaro, MC; Chehter, N; Del Nero, LG; Marta, GN; Zambon, LS, 2016) |
| "To describe the pharmacokinetic profile and clinical outcome associated with high-dose ciprofloxacin therapy in a patient with the triad of extreme obesity, multiple organ failure, and deep-seated infection." | 3.76 | High-dose ciprofloxacin for serious gram-negative infection in an obese, critically ill patient receiving continuous venovenous hemodiafiltration. ( Callcut, RA; Healy, DP; Hurford, WE; Mueller, EW; Peterson, JD; Utrup, TR, 2010) |
| "To evaluate the clinical features of ciprofloxacin-resistant Enterobacter bacteremia and to examine the risk factors for ciprofloxacin resistance in Enterobacter species isolates causing bacteremia." | 3.73 | Clinical epidemiology of ciprofloxacin resistance and its relationship to broad-spectrum cephalosporin resistance in bloodstream infections caused by Enterobacter species. ( Choe, KW; Kang, CI; Kim, EC; Kim, HB; Kim, SH; Lee, KD; Oh, MD; Park, WB, 2005) |
| "The penetration, pharmacokinetics and therapeutic efficacy of fleroxacin and pefloxacin were investigated in a rat abscess model." | 3.67 | The pharmacokinetics and therapeutic efficacy of fleroxacin and pefloxacin in a rat abscess model. ( Barzilai, A; Keren, G; Leibovitz, E; Rubinstein, E; Shabtai, M, 1989) |
| "The lower respiratory tract infections caused by E." | 2.68 | [The clinical manifestation and drug sensitive tests of lower respiratory tract infection by enterobacter cloacae. The Pulmonary Infection and Fibrosis Group, Thoracic Society Shanghai Medical Association]. ( , 1997) |
| "Complex cysts were observed by ultrasonography (in four of eight patients), computed tomography (in six of nine), and magnetic resonance imaging (in two of two)." | 2.38 | Hepatic cyst infection in autosomal dominant polycystic kidney disease. ( Brown, ML; Gross, JB; Hattery, RR; Telenti, A; Torres, VE; Van Scoy, RE, 1990) |
| "Diagnosis of postenteritic reactive arthritis (ReA) is a challenge and might have a broad range of differential diagnoses." | 1.51 | Reactive arthritis secondary to ( Bibbò, S; Colombo, E; Dore, MP; Erre, GL, 2019) |
| "This organism causes a non-specific purulent conjunctivitis that seems to have a benign course and tends to be responsive to a topical fluoroquinolone." | 1.43 | Four cases of Raoultella planticola conjunctivitis. ( Caruana, P; Cassar, R; Vassallo, J; Vella, M, 2016) |
| "Ciprofloxacin resistance has risen fairly quickly in the last four years from 1% to 8%." | 1.42 | Local audit: How tightly should we police antibiotic prescribing for urinary tract infection and how should we modify national policy? ( Brair, A; Gray, J; Toozs-Hobson, P, 2015) |
| "Crusted scabies is a severe, hyperkeratotic, psoriasiform disorder associated with immune suppression." | 1.40 | Crusted scabies of the scalp in a patient with systemic lupus erythematosus. ( Carlos, CA; Hata, T; Yee, BE, 2014) |
| "Different complications were recorded: hydrocephalus and brain abscess in one case, respiratory and hemodynamic failure managed in the intensive care unit in the second, and brain hygroma in the third case." | 1.37 | [Iatrogenic meningitis after diagnosis lumbar puncture: 3 cases reports in the paediatric Children's Hospital of Tunis]. ( Barsaoui, S; Ben Jaballah, N; Bousnina, S; Bouziri, A; Hajji, N; Hariga, D; Kechrid, A; Sammoud, A; Smaoui, H, 2011) |
| "Treatment with ciprofloxacin, a substrate of AcrAB in E." | 1.36 | Emergence of AcrAB-mediated tigecycline resistance in a clinical isolate of Enterobacter cloacae during ciprofloxacin treatment. ( Doumith, M; Ellington, MJ; Hornsey, M; Livermore, DM; Scott, G; Woodford, N, 2010) |
| "Garenoxacin is a novel des-F(6)-quinolone with a chemical structure that lacks the C6 position fluorine and has a unique difluoromethoxy substitution at position C8." | 1.34 | In vitro activity of garenoxacin tested against a worldwide collection of ciprofloxacin-susceptible and ciprofloxacin-resistant Enterobacteriaceae strains (1999-2004). ( Fritsche, TR; Jones, RN; Sader, HS, 2007) |
| "Ludwig's angina is a rapidly spreading and potentially lethal infection involving the floor of the mouth and neck." | 1.33 | A rare cause of Ludwig's angina by Morganella morganii. ( Chen, CH; Ho, MP; Lu, CL; Tsai, KC; Yen, SL, 2006) |
| "Antibiotics both prevent and treat the colitis through correction of this primary bacterial alteration." | 1.31 | Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice. ( Doyle, JS; Fedorak, RN; Jewell, LD; Madsen, KL; Rennie, RP; Tavernini, MM, 2000) |
| "Ciprofloxacin was used successfully in a neonate with ventriculitis caused by a multiply resistant strain of Enterobacter cloacae." | 1.28 | Use of ciprofloxacin in an infant with ventriculitis. ( Anderson, T; Dick, JD; Eiden, J; Goepp, JG; Lee, CK; Stokoe, JM, 1992) |
| "Fleroxacin and cefetamet were evaluated in vitro against 38 infrequently encountered species (250 strains) of the family Enterobacteriaceae and compared with four established compounds." | 1.28 | In vitro activities of fleroxacin, cefetamet, ciprofloxacin, ceftriaxone, trimethoprim-sulfamethoxazole, and amoxicillin-clavulanic acid against rare members of the family Enterobacteriaceae primarily of human (clinical) origin. ( Altwegg, M; Hohl, P; Lüthy-Hottenstein, J; Zollinger-Iten, J, 1990) |
| "Norfloxacin was ineffective at 200 mg/kg per day against E." | 1.27 | In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones. ( Bower, RR; Chu, DT; Fernandes, PB; Jarvis, KP; Ramer, NR; Shipkowitz, N, 1986) |
| "Ciprofloxacin was the most effective single agent, with efficacy against five of the six Enterobacteriaceae when used in low doses, and two of the six pseudomonads when used in high doses." | 1.27 | Ciprofloxacin, azlocillin, ceftizoxime and amikacin alone and in combination against gram-negative bacilli in an infected chamber model. ( Bamberger, DM; Fasching, CE; Gerding, DN; Moody, JA; Peterson, LR, 1986) |
| "Ciprofloxacin was effective and safe therapy of infections due to Gram-negative bacteria resistant to many of the currently available oral and parenteral agents." | 1.27 | Oral ciprofloxacin therapy of infection caused by multiply resistant bacteria other than Pseudomonas aeruginosa. ( Neu, HC; Scully, BE, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (12.84) | 18.7374 |
| 1990's | 20 (13.51) | 18.2507 |
| 2000's | 50 (33.78) | 29.6817 |
| 2010's | 55 (37.16) | 24.3611 |
| 2020's | 4 (2.70) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, JJ | 1 |
| Ko, WC | 2 |
| Tsai, SH | 1 |
| Yan, JJ | 1 |
| Tumbarello, M | 1 |
| Sanguinetti, M | 1 |
| Montuori, E | 1 |
| Trecarichi, EM | 1 |
| Posteraro, B | 1 |
| Fiori, B | 1 |
| Citton, R | 1 |
| D'Inzeo, T | 1 |
| Fadda, G | 1 |
| Cauda, R | 1 |
| Spanu, T | 1 |
| Daikos, GL | 1 |
| Kosmidis, C | 1 |
| Tassios, PT | 1 |
| Petrikkos, G | 2 |
| Vasilakopoulou, A | 1 |
| Psychogiou, M | 1 |
| Stefanou, I | 1 |
| Avlami, A | 1 |
| Katsilambros, N | 1 |
| Lartigue, MF | 1 |
| Zinsius, C | 1 |
| Wenger, A | 1 |
| Bille, J | 1 |
| Poirel, L | 1 |
| Nordmann, P | 1 |
| Strahilevitz, J | 1 |
| Engelstein, D | 1 |
| Adler, A | 2 |
| Temper, V | 1 |
| Moses, AE | 1 |
| Block, C | 1 |
| Robicsek, A | 2 |
| Pérez, A | 1 |
| Canle, D | 1 |
| Latasa, C | 1 |
| Poza, M | 1 |
| Beceiro, A | 1 |
| Tomás, Mdel M | 1 |
| Fernández, A | 1 |
| Mallo, S | 1 |
| Pérez, S | 1 |
| Molina, F | 1 |
| Villanueva, R | 1 |
| Lasa, I | 1 |
| Bou, G | 1 |
| Ambrozic Avgustin, J | 1 |
| Keber, R | 1 |
| Zerjavic, K | 1 |
| Orazem, T | 1 |
| Grabnar, M | 1 |
| Quiroga, MP | 2 |
| Andres, P | 2 |
| Petroni, A | 2 |
| Soler Bistué, AJ | 1 |
| Guerriero, L | 2 |
| Vargas, LJ | 1 |
| Zorreguieta, A | 1 |
| Tokumoto, M | 1 |
| Quiroga, C | 1 |
| Tolmasky, ME | 1 |
| Galas, M | 2 |
| Centrón, D | 2 |
| Castanheira, M | 1 |
| Sader, HS | 2 |
| Deshpande, LM | 1 |
| Fritsche, TR | 2 |
| Jones, RN | 2 |
| Espedido, BA | 1 |
| Partridge, SR | 1 |
| Iredell, JR | 1 |
| Tamang, MD | 1 |
| Seol, SY | 2 |
| Oh, JY | 1 |
| Kang, HY | 2 |
| Lee, JC | 2 |
| Lee, YC | 2 |
| Cho, DT | 2 |
| Kim, J | 2 |
| Yang, H | 1 |
| Chen, H | 2 |
| Yang, Q | 3 |
| Chen, M | 2 |
| Wang, H | 2 |
| Ma, J | 1 |
| Zeng, Z | 1 |
| Chen, Z | 1 |
| Xu, X | 2 |
| Wang, X | 2 |
| Deng, Y | 1 |
| Lü, D | 1 |
| Huang, L | 1 |
| Zhang, Y | 1 |
| Liu, J | 1 |
| Wang, M | 3 |
| Guo, Q | 1 |
| Ye, X | 1 |
| Wu, S | 1 |
| Hooper, DC | 2 |
| Sun, H | 1 |
| Xu, Y | 2 |
| Piekarska, K | 2 |
| Zacharczuk, K | 2 |
| Wołkowicz, T | 2 |
| Mokrzyś, M | 1 |
| Wolaniuk, N | 1 |
| Nowakowska, M | 1 |
| Szempliński, S | 1 |
| Dobruch, J | 1 |
| Gierczyński, R | 2 |
| Dhara, L | 1 |
| Tripathi, A | 1 |
| Jean, SS | 1 |
| Hsueh, PR | 2 |
| Kotb, DN | 1 |
| Mahdy, WK | 1 |
| Mahmoud, MS | 1 |
| Khairy, RMM | 1 |
| Begbey, A | 1 |
| Guppy, JH | 1 |
| Mohan, C | 1 |
| Webster, S | 1 |
| Wilmore, SMS | 1 |
| Kranzer, K | 1 |
| Williams, A | 1 |
| Makamure, B | 1 |
| Nhidza, AF | 1 |
| Mayini, J | 1 |
| Bandason, T | 1 |
| Metcalfe, J | 1 |
| Nicol, MP | 1 |
| Balakrishnan, I | 1 |
| Ellington, MJ | 2 |
| Woodford, N | 2 |
| Hopkins, S | 1 |
| McHugh, TD | 1 |
| Ferrand, RA | 1 |
| Varo, R | 1 |
| Sitoe, A | 1 |
| Cossa, A | 1 |
| Ordi, J | 1 |
| Rozman, M | 1 |
| Bassat, Q | 1 |
| Papakanderaki, E | 1 |
| Kanakakis, K | 1 |
| Goule, S | 1 |
| Chounti, M | 1 |
| Hountis, P | 1 |
| Kanzawa, Y | 1 |
| Ishimaru, N | 1 |
| Seto, H | 1 |
| Tsutsumi, T | 1 |
| Kinami, S | 1 |
| Soliman, AM | 1 |
| Shimamoto, T | 2 |
| Nariya, H | 1 |
| Abdel-Rahim, MH | 1 |
| El-Badawy, O | 1 |
| Hadiya, S | 1 |
| Daef, EA | 1 |
| Suh, SJ | 1 |
| Boothe, DM | 1 |
| Aly, SA | 1 |
| Chávez-Jacobo, VM | 1 |
| Hernández-Ramírez, KC | 1 |
| Silva-Sánchez, J | 1 |
| Garza-Ramos, U | 1 |
| Barrios-Camacho, H | 1 |
| Ortiz-Alvarado, R | 1 |
| Cervantes, C | 1 |
| Meza-Carmen, V | 1 |
| Ramírez-Díaz, MI | 1 |
| Frazzini, V | 1 |
| Capasso, M | 1 |
| Onofrj, M | 1 |
| Erre, GL | 1 |
| Colombo, E | 1 |
| Bibbò, S | 1 |
| Dore, MP | 1 |
| Tansarli, GS | 1 |
| Athanasiou, S | 1 |
| Falagas, ME | 1 |
| Roy, R | 1 |
| Pradeep Kumar, P | 1 |
| Malathi, J | 1 |
| Swakshyar Saumya, P | 1 |
| Krishnendu, N | 1 |
| Abhinandan, P | 1 |
| Halenka, M | 1 |
| Rzeczkowska, M | 1 |
| Chróst, A | 1 |
| Bareja, E | 1 |
| Olak, M | 1 |
| Halová, D | 1 |
| Papousek, I | 1 |
| Jamborova, I | 1 |
| Masarikova, M | 1 |
| Cizek, A | 1 |
| Janecko, N | 1 |
| Oravcova, V | 1 |
| Zurek, L | 1 |
| Clark, AB | 1 |
| Townsend, A | 1 |
| Ellis, JC | 1 |
| Literak, I | 1 |
| Bert, F | 1 |
| Larroque, B | 1 |
| Dondero, F | 1 |
| Durand, F | 1 |
| Paugam-Burtz, C | 1 |
| Belghiti, J | 1 |
| Moreau, R | 1 |
| Nicolas-Chanoine, MH | 1 |
| Treese, C | 1 |
| Pfaffenbach, S | 1 |
| Daum, S | 1 |
| Izzo, I | 1 |
| Lania, D | 1 |
| Castro, A | 1 |
| Lanzini, F | 1 |
| Bella, D | 1 |
| Pagani, A | 1 |
| Colombini, P | 1 |
| Hanna, MY | 1 |
| Tremlett, C | 1 |
| Josan, G | 1 |
| Eltom, A | 1 |
| Mills, R | 1 |
| Rochester, M | 1 |
| Livermore, DM | 3 |
| Barguigua, A | 1 |
| Ouair, H | 1 |
| El Otmani, F | 1 |
| Saile, R | 1 |
| El Mdaghri, N | 1 |
| El Azhari, M | 1 |
| Timinouni, M | 1 |
| Yee, BE | 1 |
| Carlos, CA | 1 |
| Hata, T | 1 |
| Kim, SW | 1 |
| Kim, JE | 1 |
| Hong, YA | 1 |
| Ko, GJ | 1 |
| Pyo, HJ | 1 |
| Kwon, YJ | 1 |
| Sarma, JB | 1 |
| Marshall, B | 1 |
| Cleeve, V | 1 |
| Tate, D | 1 |
| Oswald, T | 1 |
| Woolfrey, S | 1 |
| Zhang, H | 1 |
| Liao, K | 1 |
| Ni, Y | 1 |
| Yu, Y | 1 |
| Hu, B | 1 |
| Sun, Z | 1 |
| Huang, W | 1 |
| Wang, Y | 1 |
| Wu, A | 1 |
| Feng, X | 1 |
| Luo, Y | 2 |
| Hu, Z | 1 |
| Chu, Y | 1 |
| Chen, S | 2 |
| Cao, B | 1 |
| Su, J | 1 |
| Gui, B | 1 |
| Duan, Q | 1 |
| Zhang, S | 1 |
| Shao, H | 1 |
| Kong, H | 1 |
| Badal, RE | 1 |
| Valenza, G | 1 |
| Nickel, S | 1 |
| Pfeifer, Y | 1 |
| Pietsch, M | 1 |
| Voigtländer, E | 1 |
| Lehner-Reindl, V | 1 |
| Höller, C | 1 |
| Weems, MF | 1 |
| Dereddy, NR | 1 |
| Arnold, SR | 1 |
| Brair, A | 1 |
| Toozs-Hobson, P | 1 |
| Gray, J | 1 |
| Vassallo, J | 1 |
| Vella, M | 1 |
| Cassar, R | 1 |
| Caruana, P | 1 |
| Dickstein, Y | 1 |
| Geffen, Y | 1 |
| Andreassen, S | 1 |
| Leibovici, L | 1 |
| Paul, M | 1 |
| Reuland, EA | 1 |
| Sonder, GJ | 1 |
| Stolte, I | 1 |
| Al Naiemi, N | 1 |
| Koek, A | 1 |
| Linde, GB | 1 |
| van de Laar, TJ | 1 |
| Vandenbroucke-Grauls, CM | 1 |
| van Dam, AP | 1 |
| Gómez-Garcés, JL | 1 |
| Gil-Romero, Y | 1 |
| Vazquez, O | 1 |
| Merino, F | 1 |
| Zambon, LS | 1 |
| Marta, GN | 1 |
| Chehter, N | 1 |
| Del Nero, LG | 1 |
| Cavallaro, MC | 1 |
| Garcinuño, P | 1 |
| Santibañez, M | 1 |
| Gimeno, L | 1 |
| Sánchez-Bautista, A | 1 |
| Coy, J | 1 |
| Sánchez-Paya, J | 1 |
| Boix, V | 1 |
| Merino, E | 1 |
| Portilla, J | 1 |
| Rodríguez, JC | 1 |
| Albornoz, E | 1 |
| Lucero, C | 1 |
| Romero, G | 1 |
| Rapoport, M | 1 |
| Rodriguez, C | 1 |
| Corso, A | 1 |
| Sturlesi, N | 1 |
| Fallach, N | 1 |
| Zilberman-Barzilai, D | 1 |
| Hussein, O | 1 |
| Blum, SE | 1 |
| Klement, E | 1 |
| Schwaber, MJ | 1 |
| Carmeli, Y | 1 |
| Abera, B | 1 |
| Kibret, M | 1 |
| Mulu, W | 1 |
| Margaritis, A | 1 |
| Galani, I | 1 |
| Chatzikonstantinou, M | 1 |
| Souli, M | 1 |
| Boeri, L | 1 |
| Fontana, M | 1 |
| Gallioli, A | 1 |
| Zanetti, SP | 1 |
| Catellani, M | 1 |
| Longo, F | 1 |
| Mangiarotti, B | 1 |
| Montanari, E | 1 |
| McPherson, C | 1 |
| Gal, P | 1 |
| Ransom, JL | 1 |
| Perilli, M | 1 |
| Forcella, C | 1 |
| Celenza, G | 1 |
| Frascaria, P | 1 |
| Segatore, B | 1 |
| Pellegrini, C | 1 |
| Amicosante, G | 1 |
| Kanellakopoulou, K | 1 |
| Giannitsioti, E | 1 |
| Papadopoulos, A | 1 |
| Athanassia, S | 1 |
| Giamarellos-Bourboulis, EJ | 1 |
| Giamarellou, H | 1 |
| Kothari, A | 1 |
| Sagar, V | 1 |
| Hornsey, M | 1 |
| Doumith, M | 1 |
| Scott, G | 1 |
| Kaniga, K | 1 |
| Flamm, R | 1 |
| Tong, SY | 1 |
| Lee, M | 1 |
| Friedland, I | 1 |
| Redman, R | 1 |
| Mac Aogáin, M | 1 |
| Mooij, MJ | 1 |
| Adams, C | 1 |
| Clair, J | 1 |
| O'Gara, F | 1 |
| Zelenitsky, SA | 1 |
| Ariano, RE | 1 |
| Ceran, N | 1 |
| Mert, D | 1 |
| Kocdogan, FY | 1 |
| Erdem, I | 1 |
| Adalati, R | 1 |
| Ozyurek, S | 1 |
| Goktas, P | 1 |
| Utrup, TR | 1 |
| Mueller, EW | 1 |
| Healy, DP | 1 |
| Callcut, RA | 1 |
| Peterson, JD | 1 |
| Hurford, WE | 1 |
| Traoré, P | 1 |
| Coquery, S | 1 |
| Zupan-Simunek, V | 1 |
| Guibert, M | 1 |
| Boileau, P | 1 |
| Glatz, K | 1 |
| Tóth, A | 1 |
| Pászti, J | 1 |
| Smaoui, H | 1 |
| Hariga, D | 1 |
| Hajji, N | 1 |
| Bouziri, A | 1 |
| Ben Jaballah, N | 1 |
| Barsaoui, S | 1 |
| Bousnina, S | 1 |
| Sammoud, A | 1 |
| Kechrid, A | 1 |
| Shao, Y | 1 |
| Xiong, Z | 1 |
| Li, X | 1 |
| Hu, L | 1 |
| Shen, J | 1 |
| Li, T | 1 |
| Hu, F | 1 |
| Zhang, W | 1 |
| Li, J | 1 |
| Lin, L | 1 |
| Ma, Y | 1 |
| Hu, C | 1 |
| Jin, S | 1 |
| Ran, L | 1 |
| Cui, S | 1 |
| Mavroidi, A | 1 |
| Neonakis, I | 1 |
| Liakopoulos, A | 1 |
| Papaioannou, A | 1 |
| Ntala, M | 1 |
| Tryposkiadis, F | 1 |
| Miriagou, V | 1 |
| Petinaki, E | 1 |
| Ruiz, E | 1 |
| Ocampo-Sosa, AA | 1 |
| Alcoba-Flórez, J | 1 |
| Román, E | 1 |
| Arlet, G | 1 |
| Torres, C | 1 |
| Martínez-Martínez, L | 1 |
| Toh, HS | 1 |
| Chuang, YC | 1 |
| Huang, CC | 1 |
| Lee, YL | 1 |
| Liu, YM | 1 |
| Ho, CM | 1 |
| Lu, PL | 1 |
| Liu, CE | 1 |
| Chen, YH | 1 |
| Wang, JH | 1 |
| Yu, KW | 1 |
| Liu, YC | 1 |
| Chen, YS | 1 |
| Tang, HJ | 1 |
| Redondo, C | 1 |
| Chalbaud, A | 1 |
| Alonso, G | 1 |
| Nam, YS | 1 |
| Cho, SY | 1 |
| Yang, HY | 1 |
| Park, KS | 1 |
| Jang, JH | 1 |
| Kim, YT | 1 |
| Jeong, JW | 1 |
| Suh, JT | 1 |
| Lee, HJ | 1 |
| Malpas, TJ | 1 |
| Munoz, JJ | 1 |
| Muscat, I | 1 |
| Dow, G | 1 |
| Rao, P | 1 |
| Harding, G | 1 |
| Brunka, J | 1 |
| Kennedy, J | 1 |
| Alfa, M | 1 |
| Nicolle, LE | 1 |
| Nijssen, S | 1 |
| Florijn, A | 1 |
| Bonten, MJ | 1 |
| Schmitz, FJ | 1 |
| Verhoef, J | 1 |
| Fluit, AC | 1 |
| Kang, CI | 1 |
| Kim, SH | 1 |
| Park, WB | 1 |
| Lee, KD | 1 |
| Kim, HB | 1 |
| Kim, EC | 1 |
| Oh, MD | 1 |
| Choe, KW | 1 |
| Benenson, S | 1 |
| Yinnon, AM | 1 |
| Schlesinger, Y | 1 |
| Rudensky, B | 1 |
| Raveh, D | 1 |
| Ho, MP | 1 |
| Tsai, KC | 1 |
| Yen, SL | 1 |
| Lu, CL | 1 |
| Chen, CH | 1 |
| Battikhi, MN | 1 |
| Ismail, H | 1 |
| Battikhi, Q | 1 |
| Deps, PD | 1 |
| Paterson, DL | 1 |
| Park, CH | 1 |
| Jacoby, GA | 1 |
| Sahm, D | 1 |
| Hatano, K | 1 |
| Sato, M | 1 |
| Tsujimoto, Y | 1 |
| Takada, T | 1 |
| Honda, M | 1 |
| Matsumiya, K | 1 |
| Mizutani, T | 1 |
| Fujioka, H | 1 |
| Jones, SL | 1 |
| Nguyen, VK | 1 |
| Nguyen, TM | 1 |
| Athan, E | 1 |
| Huang, SS | 1 |
| Lee, MH | 1 |
| Leu, HS | 1 |
| Weile, J | 1 |
| Rahmig, H | 1 |
| Gfröer, S | 1 |
| Schroeppel, K | 1 |
| Knabbe, C | 1 |
| Susa, M | 1 |
| Kilani, B | 1 |
| Ammari, L | 1 |
| Benaïssa, HT | 1 |
| Ben Chaabane, T | 1 |
| Fendri, C | 1 |
| Corbin, A | 1 |
| Delatte, C | 1 |
| Besson, S | 1 |
| Guidry, A | 1 |
| Hoffmann, AH | 1 |
| Monier, P | 1 |
| Nathaniel, R | 1 |
| Cordeiro, NF | 1 |
| Robino, L | 1 |
| Medina, J | 1 |
| Seija, V | 1 |
| Bado, I | 1 |
| García, V | 1 |
| Berro, M | 1 |
| Pontet, J | 1 |
| López, L | 1 |
| Bazet, C | 1 |
| Rieppi, G | 1 |
| Gutkind, G | 1 |
| Ayala, JA | 1 |
| Vignoli, R | 1 |
| Wojnicz, D | 1 |
| Kłak, M | 1 |
| Adamski, R | 1 |
| Jankowski, S | 1 |
| Kienbacher, G | 1 |
| Maurer-Ertl, W | 1 |
| Glehr, M | 1 |
| Feierl, G | 1 |
| Leithner, A | 1 |
| Kim, KY | 1 |
| Khorasani, G | 1 |
| Salehifar, E | 1 |
| Eslami, G | 1 |
| Greenwood, D | 1 |
| Baxter, S | 1 |
| Cowlishaw, A | 1 |
| Eley, A | 1 |
| Slater, GJ | 1 |
| Heisig, P | 1 |
| Tzouvelekis, L | 1 |
| Vatopoulos, A | 1 |
| Legakis, N | 1 |
| Mirelis, B | 1 |
| Miro, E | 1 |
| Navarro, F | 1 |
| Ogalla, CA | 1 |
| Bonal, J | 1 |
| Prats, G | 1 |
| Demediuk, B | 1 |
| Speer, AG | 1 |
| Hellyar, A | 1 |
| D'Antuono, VS | 1 |
| Brown, I | 1 |
| Uystepruyst, P | 1 |
| Tellier, E | 1 |
| Dardenne, B | 1 |
| Darimont, M | 1 |
| van den Oever, HL | 1 |
| Versteegh, FG | 1 |
| Thewessen, EA | 1 |
| van den Anker, JN | 1 |
| Mouton, JW | 1 |
| Neijens, HJ | 1 |
| Dekitsch, C | 1 |
| Schein, R | 1 |
| Markopulos, E | 1 |
| Kuen, B | 1 |
| Graninger, W | 1 |
| Georgopoulos, A | 1 |
| Steward, CD | 1 |
| Stocker, SA | 1 |
| Swenson, JM | 1 |
| O'Hara, CM | 1 |
| Edwards, JR | 1 |
| Gaynes, RP | 1 |
| McGowan, JE | 1 |
| Tenover, FC | 1 |
| Blondeau, JM | 1 |
| Yaschuk, Y | 1 |
| Suter, M | 1 |
| Vaughan, D | 1 |
| Thomson, CJ | 1 |
| Grüneberg, R | 1 |
| Navia, MM | 1 |
| Ruiz, J | 1 |
| Ribera, A | 1 |
| de Anta, MT | 1 |
| Vila, J | 1 |
| Madsen, KL | 1 |
| Doyle, JS | 1 |
| Tavernini, MM | 1 |
| Jewell, LD | 1 |
| Rennie, RP | 1 |
| Fedorak, RN | 1 |
| Krupova, Y | 1 |
| Gould, JC | 1 |
| Strady, C | 1 |
| Bossi, P | 1 |
| Bricaire, F | 1 |
| Howard, AJ | 1 |
| Magee, JT | 1 |
| Fitzgerald, KA | 1 |
| Dunstan, FD | 1 |
| Stewart, JM | 1 |
| Quirk, JR | 1 |
| Robert, J | 1 |
| Cambau, E | 1 |
| Grenet, K | 1 |
| Trystram, D | 1 |
| Péan, Y | 1 |
| Fiévet, MH | 1 |
| Jarlier, V | 1 |
| Ratner, AJ | 1 |
| Mosca, RS | 1 |
| Zucker, HA | 1 |
| James, D | 1 |
| Reacher, M | 1 |
| Graham, C | 1 |
| Nichols, T | 1 |
| Stephens, P | 1 |
| Johnson, AP | 1 |
| George, RC | 1 |
| Garcia-Bustinduy, M | 1 |
| Lecuona, M | 1 |
| Guimera, F | 1 |
| Saez, M | 1 |
| Dorta, S | 1 |
| Sanchez, R | 1 |
| Noda, A | 1 |
| Garcia-Montelongo, R | 1 |
| Ammori, BJ | 1 |
| Zighelboim, J | 1 |
| Williams, TW | 1 |
| Bradshaw, MW | 1 |
| Harris, RL | 1 |
| Goepp, JG | 1 |
| Lee, CK | 1 |
| Anderson, T | 1 |
| Dick, JD | 1 |
| Stokoe, JM | 1 |
| Eiden, J | 1 |
| Ena, J | 1 |
| Amador, C | 1 |
| Parras, F | 1 |
| Bouza, E | 1 |
| Esposito, S | 2 |
| D'Errico, G | 2 |
| Montanaro, C | 2 |
| Hohl, P | 1 |
| Lüthy-Hottenstein, J | 1 |
| Zollinger-Iten, J | 1 |
| Altwegg, M | 1 |
| Telenti, A | 1 |
| Torres, VE | 1 |
| Gross, JB | 1 |
| Van Scoy, RE | 1 |
| Brown, ML | 1 |
| Hattery, RR | 1 |
| Leibovitz, E | 1 |
| Keren, G | 1 |
| Shabtai, M | 1 |
| Barzilai, A | 1 |
| Rubinstein, E | 1 |
| Bannon, MJ | 1 |
| Stutchfield, PR | 1 |
| Weindling, AM | 1 |
| Damjanovic, V | 1 |
| Lewandowski, A | 1 |
| Haller, I | 1 |
| Pichler, H | 1 |
| Diridl, G | 1 |
| Wolf, D | 1 |
| Guibert, J | 1 |
| Destrée, D | 1 |
| Konopka, C | 1 |
| Acar, J | 1 |
| Mehtar, S | 2 |
| Drabu, Y | 1 |
| Blakemore, P | 1 |
| Van Poppel, H | 2 |
| Wegge, M | 1 |
| Dammekens, H | 1 |
| Chysky, V | 2 |
| Hullmann, R | 1 |
| Baert, L | 1 |
| Bamberger, DM | 1 |
| Peterson, LR | 1 |
| Gerding, DN | 1 |
| Moody, JA | 1 |
| Fasching, CE | 1 |
| Langemeyer, TN | 1 |
| Ferwerda, WH | 1 |
| Hoogkamp-Korstanje, JA | 1 |
| de Leur, EJ | 1 |
| van Oort, H | 1 |
| Schipper, JJ | 1 |
| van der Wal, T | 1 |
| Blakemore, PH | 1 |
| Ellis, K | 1 |
| Boscia, JA | 1 |
| Kobasa, WD | 1 |
| Kaye, D | 1 |
| Fernandes, PB | 1 |
| Chu, DT | 1 |
| Bower, RR | 1 |
| Jarvis, KP | 1 |
| Ramer, NR | 1 |
| Shipkowitz, N | 1 |
| Newsom, SW | 1 |
| Murphy, P | 1 |
| Matthews, J | 1 |
| DuPont, HL | 1 |
| Ericsson, CD | 1 |
| Robinson, A | 1 |
| Johnson, PC | 1 |
| Greenberg, RN | 1 |
| Kennedy, DJ | 1 |
| Reilly, PM | 1 |
| Luppen, KL | 1 |
| Weinandt, WJ | 1 |
| Bollinger, MR | 1 |
| Aguirre, F | 1 |
| Kodesch, F | 1 |
| Saeed, AM | 1 |
| Scully, BE | 1 |
| Neu, HC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of the Artificial Intelligence-based Prescription Support Software iAST® for the Choice of Empirical and Semi-targeted Antibiotic Treatment[NCT06174519] | 325 participants (Actual) | Observational | 2023-08-01 | Completed | |||
| Risk-factors for Multidrug-resistant (MDR) and Extensively Drug-resistant (XDR) Bacteria Colonization Among Patients at High Risk of STIs[NCT03767374] | 2,186 participants (Actual) | Observational | 2018-05-11 | Active, not recruiting | |||
| A Multicenter, Randomized, Open-Label, Phase 3 Study to Compare the Safety and Effectiveness of Doripenem Versus a Comparator Antibiotic in Hospital-Acquired Pneumonia[NCT00211003] | Phase 3 | 240 participants (Actual) | Interventional | 2004-05-31 | Completed | ||
| A Multicenter, Double-Blind, Randomized, Phase 3 Study of Doripenem Verus a Comparator Antibiotic in the Treatment of Complicated Lower Urinary Tract Infection or Pyelonephritis[NCT00229021] | Phase 3 | 741 participants (Actual) | Interventional | 2003-12-31 | Completed | ||
| A Multicenter, Double-Blind, Randomized, Phase 3 Study of Doripenem Versus Comparator Antibiotic in the Treatment of Complicated Intra-Abdominal Infections[NCT00229060] | Phase 3 | 483 participants (Actual) | Interventional | 2004-03-31 | Completed | ||
| A Multicenter, Phase 3 Study of the Safety and Effectiveness of Doripenem in Complicated Lower Urinary Tract Infection or Pyelonephritis[NCT00210990] | Phase 3 | 403 participants (Actual) | Interventional | 2004-03-31 | Completed | ||
| A Multicenter, Double-Blind, Randomized, Phase 3 Study of Doripenem Versus Comparator Antibiotic in the Treatment of Complicated Intra-Abdominal Infections[NCT00210938] | Phase 3 | 478 participants (Actual) | Interventional | 2004-03-31 | Completed | ||
| A Multicenter, Randomized, Open-Label, Phase 3 Study of Doripenem Versus a Comparator Antibiotic in the Treatment of Ventilator-Associated Pneumonia[NCT00211016] | Phase 3 | 318 participants (Actual) | Interventional | 2004-08-31 | Completed | ||
| Controlling Antimicrobial Use Through Reducing Unnecessary Treatment of Catheter Associated Urinary Tract Infections (CARCUTI)[NCT02650518] | Phase 2/Phase 3 | 500 participants (Anticipated) | Interventional | 2015-12-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 reviews available for ciprofloxacin and Cronobacter Infections
| Article | Year |
|---|---|
Evaluation of antimicrobial susceptibility of Enterobacteriaceae causing urinary tract infections in Africa.
Topics: Africa; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Cross Infection; Databases, Factual; Drug Ev | 2013 |
Non-surgical management of thyroid abscess with ultrasound-guided fine-needle application of an antibiotic followed by sclerotization with absolute alcohol.
Topics: Abscess; Adult; Anti-Bacterial Agents; Biopsy, Fine-Needle; Ciprofloxacin; Combined Modality Therapy | 2013 |
Resistance in gram-negative bacteria: enterobacteriaceae.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Cephalosporins; Ciprofloxacin; Community- | 2006 |
Ciprofloxacin in preterm neonates: case report and review of the literature.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Multiple; Enterobacter cloacae; Enterobacteri | 1998 |
The global epidemiology of resistance to ciprofloxacin and the changing nature of antibiotic resistance: a 10 year perspective.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteria | 1999 |
Hepatic cyst infection in autosomal dominant polycystic kidney disease.
Topics: Aged; Ciprofloxacin; Cysts; Enterobacter; Enterobacteriaceae Infections; Escherichia coli Infections | 1990 |
[Ciprofloxacin--a new antibacterial drug].
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clinical Trials as Topic; Enterobacteriaceae Infections; Human | 1985 |
Clinical experience with ciprofloxacin in the treatment of urinary tract infections: a review.
Topics: Adult; Aged; Bacteriuria; Ciprofloxacin; Enterobacteriaceae Infections; Female; Humans; Male; Microb | 1988 |
Current problems in antimicrobial therapy for bacterial enteric infection.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clinical Trials as Topic; Diarrhea; Drug Combinations; Drug Re | 1987 |
10 trials available for ciprofloxacin and Cronobacter Infections
| Article | Year |
|---|---|
A randomized comparative study of single-dose fosfomycin and 5-day ciprofloxacin in female patients with uncomplicated lower urinary tract infections.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Ciprofloxacin; Drug Administration Schedule; Enterob | 2010 |
A prospective, randomized trial of 3 or 14 days of ciprofloxacin treatment for acute urinary tract infection in patients with spinal cord injury.
Topics: Acute Disease; Adult; Ciprofloxacin; Double-Blind Method; Drug Administration Schedule; Enterobacter | 2004 |
[The clinical manifestation and drug sensitive tests of lower respiratory tract infection by enterobacter cloacae. The Pulmonary Infection and Fibrosis Group, Thoracic Society Shanghai Medical Association].
Topics: Adult; Aged; Amikacin; Anti-Infective Agents; Ciprofloxacin; Drug Therapy, Combination; Enterobacter | 1997 |
Oral ciprofloxacin for treatment of acute bacterial pharyngotonsillitis.
Topics: Administration, Oral; Adult; Aged; Ciprofloxacin; Clinical Trials as Topic; Drug Administration Sche | 1990 |
Topical and oral treatment of chronic otitis media with ciprofloxacin. A preliminary study.
Topics: Administration, Oral; Administration, Topical; Adult; Chronic Disease; Ciprofloxacin; Drug Administr | 1990 |
[Ciprofloxacin--a new antibacterial drug].
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clinical Trials as Topic; Enterobacteriaceae Infections; Human | 1985 |
Ciprofloxacin in the treatment of acute bacterial diarrhea: a double blind study.
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Campylobacter fetus; Campylobacter Infections; Ci | 1986 |
Treatment of chronic bacterial prostatitis with ciprofloxacin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Ciprofloxacin; Clinical Trials as | 1987 |
A comparative study of ciprofloxacin and trimethoprim in the treatment of urinary tract infections in geriatric patients.
Topics: Aged; Ciprofloxacin; Clinical Trials as Topic; Enterobacteriaceae Infections; Humans; Prospective St | 1986 |
Current problems in antimicrobial therapy for bacterial enteric infection.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clinical Trials as Topic; Diarrhea; Drug Combinations; Drug Re | 1987 |
131 other studies available for ciprofloxacin and Cronobacter Infections
| Article | Year |
|---|---|
Prevalence of plasmid-mediated quinolone resistance determinants QnrA, QnrB, and QnrS among clinical isolates of Enterobacter cloacae in a Taiwanese hospital.
Topics: Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobact | 2007 |
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cross Infection; Drug Resistance, B | 2007 |
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cross Infection; Drug Resistance, B | 2007 |
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cross Infection; Drug Resistance, B | 2007 |
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cross Infection; Drug Resistance, B | 2007 |
Enterobacteriaceae bloodstream infections: presence of integrons, risk factors, and outcome.
Topics: Bacteremia; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Multipl | 2007 |
Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland.
Topics: Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Enterobacteriaceae; Enterobac | 2007 |
Changes in qnr prevalence and fluoroquinolone resistance in clinical isolates of Klebsiella pneumoniae and Enterobacter spp. collected from 1990 to 2005.
Topics: Anti-Infective Agents; Bacteremia; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Bacterial; En | 2007 |
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
Topics: Bacterial Proteins; Base Sequence; beta-Lactamases; Carrier Proteins; Cloning, Molecular; DNA, Bacte | 2007 |
Emergence of the quinolone resistance-mediating gene aac(6')-Ib-cr in extended-spectrum-beta-lactamase-producing Klebsiella isolates collected in Slovenia between 2000 and 2005.
Topics: beta-Lactamases; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacteriaceae Infec | 2007 |
Complex class 1 integrons with diverse variable regions, including aac(6')-Ib-cr, and a novel allele, qnrB10, associated with ISCR1 in clinical enterobacterial isolates from Argentina.
Topics: Alleles; Amino Acid Sequence; Argentina; Bacterial Proteins; Base Sequence; beta-Lactamases; Cross I | 2007 |
Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Drug Resistance, Multiple, Bacterial; En | 2008 |
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
Topics: Australia; Bacterial Proteins; beta-Lactamases; Enterobacteriaceae; Enterobacteriaceae Infections; H | 2008 |
Plasmid-mediated quinolone resistance determinants qnrA, qnrB, and qnrS among clinical isolates of Enterobacteriaceae in a Korean hospital.
Topics: Amino Acid Sequence; Base Sequence; beta-Lactam Resistance; beta-Lactamases; DNA Primers; DNA, Bacte | 2008 |
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
Topics: Acetyltransferases; Anti-Bacterial Agents; Bacterial Proteins; China; Conjugation, Genetic; Drug Res | 2008 |
High prevalence of plasmid-mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qepA among ceftiofur-resistant Enterobacteriaceae isolates from companion and food-producing animals.
Topics: Acetyltransferases; Adolescent; Adult; Aged; Animals; Animals, Domestic; Anti-Bacterial Agents; Bact | 2009 |
New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis.
Topics: Amino Acid Sequence; Anti-Infective Agents; Bacterial Proteins; Base Sequence; Conjugation, Genetic; | 2009 |
Phenotypic and genotypic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems: results from large hospital-based surveillance studies in China.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Carba | 2010 |
The molecular mechanisms of fluoroquinolone resistance found in rectal swab isolates of Enterobacterales from men undergoing a transrectal prostate biopsy: the rationale for targeted prophylaxis.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Biopsy; Ciprofloxacin; Codon; DN | 2021 |
Cinnamaldehyde: a compound with antimicrobial and synergistic activity against ESBL-producing quinolone-resistant pathogenic Enterobacteriaceae.
Topics: Acrolein; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Ciprofloxacin; Drug Resistance, Bacter | 2020 |
Antimicrobial susceptibilities of the ertapenem-non-susceptible non-carbapenemase-producing Enterobacterales isolates causing intra-abdominal infections in the Asia-Pacific region during 2008-2014: Results from the Study for Monitoring the Antimicrobial R
Topics: Amikacin; Asia; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacter; Enterobacteriaceae; Enterob | 2020 |
Impact of co-existence of PMQR genes and QRDR mutations on fluoroquinolones resistance in Enterobacteriaceae strains isolated from community and hospital acquired UTIs.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Cross Infection; Drug Resistance, B | 2019 |
Topics: Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Cl | 2020 |
Carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae in HIV-infected children in Zimbabwe.
Topics: Adolescent; Ambulatory Care; Anti-Bacterial Agents; Antiretroviral Therapy, Highly Active; beta-Lact | 2017 |
Leukoerythroblastosis in a Young Child with Severe Malaria and Superimposed Gram Negative Infection.
Topics: Anemia, Myelophthisic; Antimalarials; Blood Transfusion; Child, Preschool; Ciprofloxacin; Enterobact | 2018 |
Clinical significance of positive Raoultella Ornithinolytica and Staphylococcus hominis cultures in a post lobectomy patient. A case report.
Topics: Aged; Anti-Bacterial Agents; Carcinoma, Non-Small-Cell Lung; Ciprofloxacin; Enterobacteriaceae; Ente | 2018 |
Liver abscess with Citrobacter koseri bacteremia.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Breast Neoplasms, Male; Ciprofloxacin; Citroba | 2018 |
Emergence of
Topics: Anti-Bacterial Agents; Cephalosporins; Chloramphenicol; Chromosome Mapping; Chromosomes, Bacterial; | 2019 |
Patterns of Fluoroquinolone Resistance in Enterobacteriaceae Isolated from the Assiut University Hospitals, Egypt: A Comparative Study.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Res | 2019 |
Prevalence of the crpP gene conferring decreased ciprofloxacin susceptibility in enterobacterial clinical isolates from Mexican hospitals.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Cloning, Molecular; C | 2019 |
An Uncommon Case of Hyperammonemic Encephalopathy.
Topics: Accidental Falls; Anti-Bacterial Agents; Brain Diseases; Ciprofloxacin; Dehydration; Electroencephal | 2019 |
Reactive arthritis secondary to
Topics: Anti-Bacterial Agents; Arthritis, Reactive; Ciprofloxacin; Diagnosis, Differential; Drug Administrat | 2019 |
Endophthalmitis caused by Citrobacter species: a case series.
Topics: Aged; Anti-Bacterial Agents; Child; Ciprofloxacin; Citrobacter; Endophthalmitis; Enterobacteriaceae | 2013 |
[Occurrence and characterisation of aac(6')-Ib-cr gene encoding fluoroquinolone-modifying enzyme in clinical ciprofloxacin-resistant Enterobacteriaceae strains isolated in Poland].
Topics: Acetyltransferases; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacteriacea | 2013 |
Plasmid-mediated quinolone resistance genes in Enterobacteriaceae from American crows: high prevalence of bacteria with variable qnrB genes.
Topics: Animals; Anti-Bacterial Agents; Base Sequence; Bird Diseases; Ciprofloxacin; Crows; Drug Resistance, | 2014 |
Risk factors associated with preoperative fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in liver transplant recipients.
Topics: Adult; Amikacin; beta-Lactamases; beta-Lactams; Cefoxitin; Ciprofloxacin; Drug Resistance, Bacterial | 2014 |
Uncommon case of ulcerative esophagitis.
Topics: Anti-Bacterial Agents; Biopsy; Ciprofloxacin; Enterobacter cloacae; Enterobacteriaceae Infections; E | 2014 |
[Seven cases of port-a-cath contamination caused by Pantoea agglomerans in the Oncological Service of Iseo Hospital, Brescia (Italy)].
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents, Local; Catheter-Related Infections; Catheterizat | 2014 |
Prevalence of ciprofloxacin-resistant Enterobacteriaceae in the intestinal flora of patients undergoing transrectal prostate biopsy in Norwich, UK.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biopsy; Ciprofloxacin; Drug Resistance, Bacteri | 2015 |
Fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in community setting in Casablanca.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carrier State; Ciproflo | 2015 |
Crusted scabies of the scalp in a patient with systemic lupus erythematosus.
Topics: Adult; Anti-Bacterial Agents; Antiparasitic Agents; Ciprofloxacin; Enterobacter cloacae; Enterobacte | 2014 |
Raoultella planticola peritonitis in a patient on continuous ambulatory peritoneal dialysis.
Topics: Aged; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Enterobacteriaceae; Enterobacteriaceae Infe | 2015 |
Effects of fluoroquinolone restriction (from 2007 to 2012) on resistance in Enterobacteriaceae: interrupted time-series analysis.
Topics: Anti-Bacterial Agents; beta-Lactamases; Ciprofloxacin; Cross Infection; Enterobacteriaceae Infection | 2015 |
Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; China; Ciprof | 2016 |
Prevalence and genetic diversity of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in nursing homes in Bavaria, Germany.
Topics: Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; beta-Lactamases; Ciprofloxacin; Drug Resist | 2017 |
Mother's Milk as a Source of Enterobacter cloacae Sepsis in a Preterm Infant.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Bottle Feeding; Breast Feeding; Breast Milk Expression; Ca | 2015 |
Local audit: How tightly should we police antibiotic prescribing for urinary tract infection and how should we modify national policy?
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Clinical Audit; | 2015 |
Four cases of Raoultella planticola conjunctivitis.
Topics: Administration, Topical; Adolescent; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; | 2016 |
Predicting Antibiotic Resistance in Urinary Tract Infection Patients with Prior Urine Cultures.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Ciprofloxacin; Drug Resistance, Multiple, | 2016 |
Travel to Asia and traveller's diarrhoea with antibiotic treatment are independent risk factors for acquiring ciprofloxacin-resistant and extended spectrum β-lactamase-producing Enterobacteriaceae-a prospective cohort study.
Topics: Adult; Anti-Bacterial Agents; Asia; beta-Lactamases; Ciprofloxacin; Cohort Studies; Diarrhea; Drug R | 2016 |
[Synergistic activity and clinical efficacy of fosfomycin and ciprofloxacin combination treatment for soft tissue infection caused by carbapenemase-producing Enterobacter cloacae].
Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Ciprofloxacin; Colonic D | 2017 |
Near-drowning-associated pneumonia with bacteremia caused by coinfection with methicillin-susceptible Staphylococcus aureus and Edwardsiella tarda in a healthy white man: a case report.
Topics: Adult; Bacteremia; Ceftriaxone; Ciprofloxacin; Clindamycin; Coinfection; Edwardsiella tarda; Enterob | 2016 |
Empirical monotherapy with meropenem or combination therapy: the microbiological point of view.
Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Drug Therapy, Combinatio | 2016 |
Prevalence of Plasmid-Mediated Quinolone Resistance Genes in Clinical Enterobacteria from Argentina.
Topics: Anti-Bacterial Agents; Argentina; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Bacterial; Ent | 2017 |
Gentamicin- and Ciprofloxacin-Resistant Enterobacteriaceae in Cattle Farms in Israel: Risk Factors for Carriage and the Effect of Microbiological Methodology on the Measured Prevalence.
Topics: Age Factors; Animal Husbandry; Animals; Anti-Bacterial Agents; Carrier State; Cattle; Cattle Disease | 2017 |
Extended-Spectrum beta (β)-Lactamases and Antibiogram in Enterobacteriaceae from Clinical and Drinking Water Sources from Bahir Dar City, Ethiopia.
Topics: Adult; Age Factors; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Child, Preschool; Chloramphe | 2016 |
Plasmid-mediated quinolone resistance determinants among Gram-negative bacteraemia isolates: a hidden threat.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; | 2017 |
Rectal Culture-Guided Targeted Antimicrobial Prophylaxis Reduces the Incidence of Post-Operative Infectious Complications in Men at High Risk for Infections Submitted to Transrectal Ultrasound Prostate Biopsy - Results of a Cross-Sectional Study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biopsy, Needle; Ciprofloxaci | 2017 |
Treatment of Citrobacter koseri infection with ciprofloxacin and cefotaxime in a preterm infant.
Topics: Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Citrobacter koseri; Drug Therapy, Combination; Ent | 2008 |
Evidence for qnrB1 and aac(6')-Ib-cr in CTX-M-15-producing uropathogenic Enterobacteriaceae in an Italian teaching hospital.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ciprofloxacin; Drug Resistanc | 2009 |
Chronic bone infections due to Enterobacter cloacae: current therapeutic trends and clinical outcome.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bone Diseases, Infectious; Carbapenems; Chronic Dise | 2009 |
Antibiotic resistance in pathogens causing community-acquired urinary tract infections in India: a multicenter study.
Topics: Adolescent; Adult; Aged; Ampicillin; Anti-Infective Agents, Urinary; Ciprofloxacin; Community-Acquir | 2008 |
Emergence of AcrAB-mediated tigecycline resistance in a clinical isolate of Enterobacter cloacae during ciprofloxacin treatment.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Bacteriophage lambda; Ciprof | 2010 |
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase II | 2010 |
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase II | 2010 |
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase II | 2010 |
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase II | 2010 |
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase II | 2010 |
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase II | 2010 |
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase II | 2010 |
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase II | 2010 |
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase II | 2010 |
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase II | 2010 |
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase II | 2010 |
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase II | 2010 |
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase II | 2010 |
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase II | 2010 |
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase II | 2010 |
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase II | 2010 |
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase II | 2010 |
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase II | 2010 |
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase II | 2010 |
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase II | 2010 |
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase II | 2010 |
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase II | 2010 |
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase II | 2010 |
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase II | 2010 |
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase II | 2010 |
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase II | 2010 |
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase II | 2010 |
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase II | 2010 |
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase II | 2010 |
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase II | 2010 |
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase II | 2010 |
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase II | 2010 |
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase II | 2010 |
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase II | 2010 |
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase II | 2010 |
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase II | 2010 |
Emergence of extended-spectrum beta-lactamase and fluoroquinolone resistance genes among Irish multidrug-resistant isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Ciprofloxacin; Drug Resi | 2010 |
Support for higher ciprofloxacin AUC 24/MIC targets in treating Enterobacteriaceae bloodstream infection.
Topics: Aged; Anti-Bacterial Agents; Area Under Curve; Ciprofloxacin; Enterobacteriaceae; Enterobacteriaceae | 2010 |
High-dose ciprofloxacin for serious gram-negative infection in an obese, critically ill patient receiving continuous venovenous hemodiafiltration.
Topics: Anti-Infective Agents; Ciprofloxacin; Critical Illness; Enterobacter aerogenes; Enterobacteriaceae I | 2010 |
[Multiple brain abscesses complicating Enterobacter cloacae sepsis in a premature infant].
Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Ciprofloxacin; Enterobacter cloacae; Ente | 2010 |
The cyclohexane tolerance and Phe-Arg-β-naphtylamide susceptibility of multidrug-resistant Enterobacter cloacae clinical isolates, and the predominance of one PFGE clone in Hungary.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Ciprofloxacin; Cyclohexanes; Dipeptides; Disk Di | 2011 |
[Iatrogenic meningitis after diagnosis lumbar puncture: 3 cases reports in the paediatric Children's Hospital of Tunis].
Topics: beta-Lactam Resistance; Brain Abscess; Brain Damage, Chronic; Ciprofloxacin; Drug Therapy, Combinati | 2011 |
Prevalence of plasmid-mediated quinolone resistance determinants in Citrobacter freundii isolates from Anhui province, PR China.
Topics: China; Ciprofloxacin; Citrobacter freundii; Conjugation, Genetic; Drug Resistance, Bacterial; Entero | 2011 |
Wide dissemination of multidrug-resistant Shigella isolates in China.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Base Sequence; beta-Lactamases; Cephalosporins; | 2011 |
Detection of Citrobacter koseri carrying beta-lactamase KPC-2 in a hospitalised patient, Greece, July 2011.
Topics: Aged, 80 and over; Bacterial Proteins; beta-Lactamases; Ciprofloxacin; Citrobacter koseri; Drug Resi | 2011 |
Changes in ciprofloxacin resistance levels in Enterobacter aerogenes isolates associated with variable expression of the aac(6')-Ib-cr gene.
Topics: Acetyltransferases; Anti-Bacterial Agents; Base Sequence; Ciprofloxacin; Drug Resistance, Bacterial; | 2012 |
Antimicrobial susceptibility profiles of Gram-negative bacilli isolated from patients with hepatobiliary infections in Taiwan: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2006-2010.
Topics: Anti-Bacterial Agents; beta-Lactamases; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Ente | 2012 |
Frequency and diversity of CTX-M enzymes among extended-spectrum beta-lactamase-producing Enterobacteriaceae isolates from Caracas, Venezuela.
Topics: Anti-Bacterial Agents; beta-Lactamases; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterob | 2013 |
Investigation of mutation distribution in DNA gyrase and topoisomerase IV genes in ciprofloxacin-non-susceptible Enterobacteriaceae isolated from blood cultures in a tertiary care university hospital in South Korea, 2005-2010.
Topics: Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA, Bacterial; | 2013 |
Vertical transmission of Citrobacter freundii.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Citrobacter freundii; Enterobacteriaceae Infections; Humans; I | 2004 |
Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates.
Topics: Aztreonam; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cephalo | 2004 |
Clinical epidemiology of ciprofloxacin resistance and its relationship to broad-spectrum cephalosporin resistance in bloodstream infections caused by Enterobacter species.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Bacteremia; Case-Control Studies; Cephalosporins; Ci | 2005 |
Optimization of empirical antibiotic selection for suspected Gram-negative bacteraemia in the emergency department.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Child; Ciprofloxacin; Diabetes Co | 2005 |
A rare cause of Ludwig's angina by Morganella morganii.
Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Enterobacteriaceae Infections; Humans; Ludwig's Angina; | 2006 |
Effects of chronic bacterial prostatitis on prostate specific antigen levels total and free in patients with benign prostatic hyperplasia and prostate cancer.
Topics: Adult; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Ciprofloxaci | 2006 |
Scalp abscess due to Enterobacter agglomerans.
Topics: Abscess; Adolescent; Anti-Infective Agents; Ciprofloxacin; Enterobacter; Enterobacteriaceae Infectio | 2006 |
Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme.
Topics: Acetyltransferases; Anti-Bacterial Agents; Ciprofloxacin; Cross-Sectional Studies; Drug Resistance, | 2006 |
[Pyogenic spondylitis by Enterobacter cloacae as a postoperative complication of TURP: a case report].
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Enterobacter cloacae; Enterobacte | 2006 |
Prevalence of multiresistant Gram-negative organisms in a surgical hospital in Ho Chi Minh City, Vietnam.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporin Resistance; Ciprofloxacin; Cross Infection; Dr | 2006 |
Bacteremia due to extended-spectrum beta-lactamase-producing Enterobacteriaceae other than Escherichia coli and Klebsiella.
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; | 2006 |
First detection of a VIM-1 metallo-beta-lactamase in a carbapenem-resistant Citrobacter freundii clinical isolate in an acute hospital in Germany.
Topics: Aged, 80 and over; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cilastatin; Ciprofloxacin; | 2007 |
In vitro activity of garenoxacin tested against a worldwide collection of ciprofloxacin-susceptible and ciprofloxacin-resistant Enterobacteriaceae strains (1999-2004).
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteria | 2007 |
Escherichia vulneris as a cause of bacteremia in a patient with chronic lymphocytic leukemia.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Drug Therapy, Combination; Enterobacteriacea | 2008 |
Budvicia aquatica sepsis in an immunocompromised patient following exposure to the aftermath of Hurricane Katrina.
Topics: Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Disasters; Enterobacteriaceae; Enterobacter | 2007 |
Ciprofloxacin-resistant enterobacteria harboring the aac(6')-Ib-cr variant isolated from feces of inpatients in an intensive care unit in Uruguay.
Topics: Acetyltransferases; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacteria | 2008 |
Influence of subinhibitory concentrations of amikacin and ciprofloxacin on morphology and adherence ability of uropathogenic strains.
Topics: Amikacin; Anti-Infective Agents; Bacterial Adhesion; Ciprofloxacin; Enterobacteriaceae; Enterobacter | 2007 |
[A case of a tumorsimulating expansion caused by anabolic androgen steroids in body building].
Topics: Abscess; Adult; Anabolic Agents; Androgens; Arm; Ciprofloxacin; Debridement; Diagnosis, Differential | 2007 |
Distribution of conjugative-plasmid-mediated 16S rRNA methylase genes among amikacin-resistant Enterobacteriaceae isolates collected in 1995 to 1998 and 2001 to 2006 at a university hospital in South Korea and identification of conjugative plasmids mediat
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Proteins; Cefotaxime; Ciprofloxacin; Conjugation, Genetic | 2008 |
Profile of microorganisms and antimicrobial resistance at a tertiary care referral burn centre in Iran: emergence of Citrobacter freundii as a common microorganism.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Burns; Child; Ciprofloxacin; Citr | 2008 |
Antibacterial activity of ciprofloxacin in conventional tests and in a model of bacterial cystitis.
Topics: Anti-Infective Agents, Urinary; Ciprofloxacin; Cystitis; Dose-Response Relationship, Drug; Drug Resi | 1984 |
Ciprofloxacin resistance in enterobacterial clinical isolates.
Topics: Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans | 1994 |
Increased resistance to quinolone in Catalonia, Spain.
Topics: Anti-Infective Agents; Campylobacter Infections; Ciprofloxacin; Drug Resistance, Microbial; Enteroba | 1993 |
Induced antibiotic-resistant bacteria in cholangitis with biliary stasis.
Topics: Aged; Anti-Infective Agents; Cholangitis; Cholestasis; Ciprofloxacin; Enterobacter cloacae; Enteroba | 1996 |
Successful treatment of enterobacter meningitis with ciprofloxacin.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Enterobacter; Enterobacteriaceae Infections; Female; Hu | 1998 |
[Reiter syndrome: apropos of a case].
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthri | 1998 |
Analysis of mutations to gyrA in quinolone-resistant clinical isolates of Enterobacter cloacae.
Topics: Amino Acid Substitution; Anti-Infective Agents; Ciprofloxacin; Codon; Deoxyribonucleases, Type II Si | 1999 |
Comparison of agar dilution, disk diffusion, MicroScan, and Vitek antimicrobial susceptibility testing methods to broth microdilution for detection of fluoroquinolone-resistant isolates of the family Enterobacteriaceae.
Topics: Anti-Infective Agents; Ciprofloxacin; Culture Media; Drug Resistance, Microbial; Enterobacteriaceae; | 1999 |
In-vitro susceptibility of 1982 respiratory tract pathogens and 1921 urinary tract pathogens against 19 antimicrobial agents: a Canadian multicentre study. Canadian Antimicrobial Study Group.
Topics: Acinetobacter; Anti-Bacterial Agents; Cefoperazone; Ceftazidime; Ciprofloxacin; Clavulanic Acids; En | 1999 |
Ten years of ciprofloxacin: the past, present and future. Genitourinary infections. Introduction.
Topics: Anti-Infective Agents; Ciprofloxacin; Enterobacteriaceae Infections; Humans; Urinary Tract Infection | 1999 |
Analysis of the mechanisms of quinolone resistance in clinical isolates of Citrobacter freundii.
Topics: Amino Acid Sequence; Anti-Infective Agents; Bacterial Outer Membrane Proteins; Ciprofloxacin; Citrob | 1999 |
Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice.
Topics: Age Factors; Animals; Anti-Bacterial Agents; Bacteroides; Ciprofloxacin; Clostridium; Colitis; Enter | 2000 |
The relationship between resistance in bacteria and antibiotic use in neurology and haematology units.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Drug Utilization; Enterobacteriace | 2000 |
[Spondylodiscitis caused by Enterobacter aerogenes].
Topics: Anti-Bacterial Agents; Ciprofloxacin; Discitis; Drug Therapy, Combination; Enterobacter aerogenes; E | 2000 |
Factors associated with antibiotic resistance in coliform organisms from community urinary tract infection in Wales.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Ampicilli | 2001 |
Community-acquired pneumonia caused by Enterobacter asburiae.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Community-Acquired Infections; Enterobacteriaceae Infec | 2001 |
Trends in quinolone susceptibility of Enterobacteriaceae among inpatients of a large university hospital: 1992-98.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteria | 2001 |
Citrobacter mediastinitis following cardiac surgery in a neonate.
Topics: Anti-Infective Agents; Cardiac Surgical Procedures; Ciprofloxacin; Citrobacter; Cross Infection; Ent | 2002 |
Trends in fluoroquinolone (ciprofloxacin) resistance in enterobacteriaceae from bacteremias, England and Wales, 1990-1999.
Topics: Bacteremia; Ciprofloxacin; Drug Resistance, Bacterial; Drug Utilization; England; Enterobacteriaceae | 2002 |
Citrobacter koseri in scalp folliculitis.
Topics: Anti-Infective Agents; Ciprofloxacin; Citrobacter; Enterobacteriaceae Infections; Folliculitis; Huma | 2002 |
Laparoscopic transgastric pancreatic necrosectomy for infected pancreatic necrosis.
Topics: Aged; Amylases; Anti-Bacterial Agents; Blood Loss, Surgical; Ciprofloxacin; Debridement; Enterobacte | 2002 |
Successful medical management of a patient with multiple hepatic abscesses due to Edwardsiella tarda.
Topics: Adult; Ceftriaxone; Cilastatin; Ciprofloxacin; Drug Therapy, Combination; Enterobacteriaceae Infecti | 1992 |
Use of ciprofloxacin in an infant with ventriculitis.
Topics: Cerebral Ventricles; Ciprofloxacin; Drug Resistance, Microbial; Encephalitis; Enterobacter cloacae; | 1992 |
Ciprofloxacin as an effective antibacterial agent in serratia endocarditis.
Topics: Adult; Ciprofloxacin; Endocarditis, Bacterial; Enterobacteriaceae Infections; Female; Humans; Inject | 1991 |
In vitro activities of fleroxacin, cefetamet, ciprofloxacin, ceftriaxone, trimethoprim-sulfamethoxazole, and amoxicillin-clavulanic acid against rare members of the family Enterobacteriaceae primarily of human (clinical) origin.
Topics: Amoxicillin; Anti-Bacterial Agents; Ceftizoxime; Ceftriaxone; Ciprofloxacin; Clavulanic Acid; Clavul | 1990 |
The pharmacokinetics and therapeutic efficacy of fleroxacin and pefloxacin in a rat abscess model.
Topics: Abscess; Animals; Anti-Bacterial Agents; Ciprofloxacin; Colony Count, Microbial; Disease Models, Ani | 1989 |
Ciprofloxacin in neonatal Enterobacter cloacae septicaemia.
Topics: Ciprofloxacin; Enterobacter; Enterobacteriaceae Infections; Humans; Infant, Newborn; Infant, Prematu | 1989 |
Comprehensive evaluation of ciprofloxacin-aminoglycoside combinations against Enterobacteriaceae and Pseudomonas aeruginosa strains.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Ciprofloxacin; Drug Therapy, Combination; Enterobac | 1985 |
Ciprofloxacin in the treatment of urinary tract infection due to enterobacteria.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Bacterial Agents; Ciprofloxacin; Cystitis; Drug | 1986 |
Ciprofloxacin in the treatment of infections caused by gentamicin-resistant gram-negative bacteria.
Topics: Anti-Bacterial Agents; Bacterial Infections; Bone Diseases; Catheters, Indwelling; Ciprofloxacin; Dr | 1986 |
Ciprofloxacin in the treatment of urinary tract infection in patients with multiple sclerosis.
Topics: Anti-Infective Agents; Catheters, Indwelling; Ciprofloxacin; Cystitis; Enterobacteriaceae Infections | 1986 |
Ciprofloxacin, azlocillin, ceftizoxime and amikacin alone and in combination against gram-negative bacilli in an infected chamber model.
Topics: Amikacin; Animals; Azlocillin; Cefotaxime; Ceftizoxime; Ciprofloxacin; Drug Synergism; Drug Therapy, | 1986 |
In vivo effect of ciprofloxacin on plasmid-mediated resistance.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae Infections; Hum | 1987 |
Comparison of difloxacin, enoxacin, and cefoperazone for treatment of experimental Enterobacter aerogenes endocarditis.
Topics: Animals; Anti-Bacterial Agents; Cefoperazone; Ciprofloxacin; Endocarditis, Bacterial; Enoxacin; Ente | 1987 |
In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Enterobacteriaceae In | 1986 |
Treatment of bone, joint, and soft-tissue infections with oral ciprofloxacin.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Cellulitis; Ciprofloxacin; Enterob | 1987 |
Oral ciprofloxacin therapy of infection caused by multiply resistant bacteria other than Pseudomonas aeruginosa.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Bacterial Infections; Ciprofloxacin; Drug Resi | 1986 |